Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Vivos Therapeutics (VVOS) Preferred Shares Repurchased (2020)

Vivos Therapeutics (VVOS) has disclosed Preferred Shares Repurchased for 1 consecutive years, with $2.0 million as the latest value for Q4 2020.

  • On a quarterly basis, Preferred Shares Repurchased changed N/A to $2.0 million in Q4 2020 year-over-year; TTM through Dec 2021 was $2.0 million, a 6.98% decrease, with the full-year FY2021 number at $1.5 million, down 30.23% from a year prior.
  • Preferred Shares Repurchased was $2.0 million for Q4 2020 at Vivos Therapeutics, up from $150000.0 in the prior quarter.
  • In the past five years, Preferred Shares Repurchased ranged from a high of $2.0 million in Q4 2020 to a low of $150000.0 in Q1 2020.